A new study, published in the journal Cell Stem Cell, has reported a significant stride in the quest to generate sperm cells in a laboratory setting. Researchers successfully matured early-stage male germ cells from both human and macaque pluripotent stem cells, bringing the scientific community closer to understanding and potentially treating male infertility.
The study, led by Eoin C. Whelan and colleagues, details a method that not only advances the maturation of these cells but also observes them self-assembling into structures resembling seminiferous tubules – the natural sites of sperm production within the testicles. This groundbreaking development provides a novel model system that could be instrumental in dissecting the complex biological processes behind sperm formation and identifying why these processes fail in some infertile men.
Dr Harry Leitch, Associate Professor in Clinical Genetics & Genomic Medicine at UCL Great Ormond Street Institute of Child Health, commented on the findings, stating that the research “pushes the field forwards.” He highlighted that while previous work in mice has led to the creation of functional sperm and eggs capable of producing live animals, human stem cell research has, until now, only managed to create the earliest stages of germ cells. This latest study, he notes, represents a crucial step in advancing human germ cell maturation.
Professor Allan Pacey, Professor of Andrology at the University of Manchester, echoed this sentiment, describing the paper as “interesting” and a “great step forward.” He emphasised two key possibilities arising from the research: the creation of an invaluable laboratory model to investigate the causes of male infertility, and a significant advancement on the path towards eventually creating sperm for infertile men in the laboratory. However, both experts underscored that the cells produced in this study are not yet functional sperm capable of fertilisation, and much more research is required.
The implications for future infertility treatments are substantial, though significant ethical and regulatory hurdles remain. Professor Pacey pointed out that even if functional sperm were to be produced in the lab, current UK law prohibits their use in infertility treatments without a change in legislation, which would necessitate extensive safety data and public discussion. Despite these challenges, the study marks a high-quality contribution from a leading research group, directly comparing lab-grown cells with natural cells to ensure their close approximation to normal development.